NOX 2.94% 6.6¢ noxopharm limited

News: NOX Noxopharm Announces Results From Novel Dual-Cell Therapy Pancreatic Cancer Study, page-5

  1. 418 Posts.
    lightbulb Created with Sketch. 204
    It’s interesting that the new method devised by UNSW is not yet recognized by the regulatory body and that NOX has to go backwards to move forwards. At least pre-clinical work is comparatively cheap.

    It would be great if NOX are able to release efficacy data in any one of the three clinical trials on the back of this announcement. With the media push on this announcement there could be alot of new faces to drive a much needed re-rate before the next cap raise.

    https://hotcopper.com.au/data/attachments/4676/4676996-a6bf11861b96a6887605a3031967b1c1.jpg

 
watchlist Created with Sketch. Add NOX (ASX) to my watchlist
(20min delay)
Last
6.6¢
Change
-0.002(2.94%)
Mkt cap ! $19.28M
Open High Low Value Volume
6.7¢ 6.9¢ 6.6¢ $13.31K 198.1K

Buyers (Bids)

No. Vol. Price($)
1 1137 6.6¢
 

Sellers (Offers)

Price($) Vol. No.
6.7¢ 22400 1
View Market Depth
Last trade - 15.50pm 28/06/2024 (20 minute delay) ?
NOX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.